Literature DB >> 21516136

Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts.

Dong-wook Han1, Mi Hee Lee, Hak Hee Kim, Suong-hyu Hyon, Jong-chul Park.   

Abstract

AIM: To investigate the effects of (-)epigallocatechin-3-gallate (EGCG), the main polyphenol in green tea, on cell growth, cell cycle and phosphorylated nuclear factor-κB (pNF-κB) expression in neonatal human dermal fibroblasts (nHDFs).
METHODS: The proliferation and cell-cycle of nHDFs were determined using WST-8 cell growth assay and flow cytometry, respectively. The apoptosis was examined using DNA ladder and Annexin V-FITC assays. The expression levels of pNF-κB and cell cycle-related genes and proteins in nHDFs were measured using cDNA microarray analyses and Western blot. The cellular uptake of EGCG was examined using fluorescence (FITC)-labeled EGCG (FITC-EGCG) in combination with confocal microscopy.
RESULTS: The effect of EGCG on the growth of nHDFs depended on the concentration tested. At a low concentration (200 μmol/L), EGCG resulted in a slight decrease in the proportion of cells in the S and G(2)/M phases of cell cycle with a concomitant increase in the proportion of cells in G(0)/G(1) phase. At the higher doses (400 and 800 μmol/L), apoptosis was induced. The regulation of EGCG on the expression of pNF-κB was also concentration-dependent, whereas it did not affect the unphosphorylated NF-κB expression. cDNA microarray analysis showed that cell cycle-related genes were down-regulated by EGCG (200 μmol/L). The expression of cyclins A/B and cyclin-dependent kinase 1 was reversibly regulated by EGCG (200 μmol/L). FITC-EGCG was found to be internalized into the cytoplasm and translocated into the nucleus of nHDFs.
CONCLUSION: EGCG, through uptake into cytoplasm, reversibly regulated the cell growth and expression of cell cycle-related proteins and genes in normal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21516136      PMCID: PMC4002512          DOI: 10.1038/aps.2011.17

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  32 in total

1.  Comparative study on motility of the cultured fetal and neonatal dermal fibroblasts in extracellular matrix.

Authors:  J C Park; B J Park; H Suh; B Y Park; D K Rah
Journal:  Yonsei Med J       Date:  2001-12       Impact factor: 2.759

2.  Reduced glutathione and S-acetylglutathione as selective apoptosis-inducing agents in cancer therapy.

Authors:  B Donnerstag; G Ohlenschlager; J Cinatl; M Amrani; D Hofmann; S Flindt; G Treusch; L Träger
Journal:  Cancer Lett       Date:  1996-12-20       Impact factor: 8.679

3.  Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells.

Authors:  N Ahmad; S Gupta; M M Husain; K M Heiskanen; H Mukhtar
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

4.  Synthesis of (-)-[4-3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration.

Authors:  T Kohri; F Nanjo; M Suzuki; R Seto; N Matsumoto; M Yamakawa; H Hojo; Y Hara; D Desai; S Amin; C C Conaway; F L Chung
Journal:  J Agric Food Chem       Date:  2001-02       Impact factor: 5.279

5.  Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.

Authors:  Mi Hee Lee; Dong-Wook Han; Suong-Hyu Hyon; Jong-Chul Park
Journal:  Apoptosis       Date:  2011-01       Impact factor: 4.677

6.  Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.

Authors:  N D Perkins; L K Felzien; J C Betts; K Leung; D H Beach; G J Nabel
Journal:  Science       Date:  1997-01-24       Impact factor: 47.728

7.  Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.

Authors:  Robert R Swezey; Daphne E Aldridge; Susanna E LeValley; James A Crowell; Yukihiko Hara; Carol E Green
Journal:  Int J Toxicol       Date:  2003 May-Jun       Impact factor: 2.032

8.  Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

Authors:  H-H Sherry Chow; Yan Cai; Iman A Hakim; James A Crowell; Farah Shahi; Chris A Brooks; Robert T Dorr; Yukihiko Hara; David S Alberts
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

9.  Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.

Authors:  Jungil Hong; Hong Lu; Xiaofeng Meng; Jae-Ha Ryu; Yukihiko Hara; Chung S Yang
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

10.  A receptor for green tea polyphenol EGCG.

Authors:  Hirofumi Tachibana; Kiyoshi Koga; Yoshinori Fujimura; Koji Yamada
Journal:  Nat Struct Mol Biol       Date:  2004-03-14       Impact factor: 15.369

View more
  8 in total

1.  Augmented anti-angiogenesis activity of polysulfated heparin-endostatin and polyethylene glycol-endostatin in alkali burn-induced corneal ulcers in rabbits.

Authors:  Zhao-Na Li; Zhong-Fang Yuan; Guo-Ying Mu; Ming Hu; Li-Jun Cao; Ya-Li Zhang; Ming-Xu Ge
Journal:  Exp Ther Med       Date:  2015-06-29       Impact factor: 2.447

2.  Punicalagin inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPKs and NF-κB activation.

Authors:  Xiaolong Xu; Peng Yin; Changrong Wan; Xinlu Chong; Mingjiang Liu; Peng Cheng; Jiajia Chen; Fenghua Liu; Jianqin Xu
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

3.  Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoids.

Authors:  Irina Baran; Constanta Ganea; Simona Privitera; Agata Scordino; Vincenza Barresi; Francesco Musumeci; Maria Magdalena Mocanu; Daniele F Condorelli; Ioan Ursu; Rosaria Grasso; Marisa Gulino; Alexandru Garaiman; Nicolò Musso; Giuseppe A Pablo Cirrone; Giacomo Cuttone
Journal:  Oxid Med Cell Longev       Date:  2012-07-03       Impact factor: 6.543

4.  Functional testing of topical skin formulations using an optimised ex vivo skin organ culture model.

Authors:  G P Sidgwick; D McGeorge; A Bayat
Journal:  Arch Dermatol Res       Date:  2016-04-16       Impact factor: 3.017

5.  Polyphenol Polymerization by an Alternative Oxidative Microbial Enzyme and Characterization of the Biological Activity of Oligomers.

Authors:  Patrizia Di Gennaro; Valentina Sabatini; Silvia Fallarini; Roberto Pagliarin; Guido Sello
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

6.  The effect of down-regulation of CCL5 on lipopolysaccharide-induced WI-38 fibroblast injury: a potential role for infantile pneumonia.

Authors:  Dong Bai; Anbang Han; Shan Cong
Journal:  Iran J Basic Med Sci       Date:  2018-05       Impact factor: 2.699

7.  Preventive effects of epigallocatechin-3-O-gallate against replicative senescence associated with p53 acetylation in human dermal fibroblasts.

Authors:  Dong-Wook Han; Mi Hee Lee; Bongju Kim; Jun Jae Lee; Suong-Hyu Hyon; Jong-Chul Park
Journal:  Oxid Med Cell Longev       Date:  2012-11-18       Impact factor: 6.543

8.  Epigallocatechin-3-Gallate Promotes the Growth of Mink Hair Follicles Through Sonic Hedgehog and Protein Kinase B Signaling Pathways.

Authors:  Haihua Zhang; Weixiao Nan; Shiyong Wang; Xingchao Song; Huazhe Si; Tong Li; Guangyu Li
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.